drugset / Trial / NCT00304772
Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to verify the equivalence in clinical efficacy of fluconazole and micafungin for the treatment of Candida bloodstream infection in non-neutropenic patients.
Timeline
- Start
- 2006-08
- Primary completion
- 2008-12
- Completion
- 2008-12
Outcome
Outcome not reported
Stopped (Enrollment): “Subjects were not recruited as intended.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluconazole | Small molecule | 400 mg | — |
| Comparator | Micafungin | Peptide | 150 mg | — |